Table of Contents

<< Previous Issue

May 2023 (Vol: 2023, Issue: 5)

Section: Licensing
Pipeline Therapeutics Signs Licensing Agreement with Janssen for Investigational Neurotherapeutic, PIPE-307 Published: 11 May-2023
By: Shweta Gupta
Abstract Fulltext:
Janssen Signs Collaboration and License Agreement with Cellular Biomedicine to Develop CAR-T Therapies Published: 18 May-2023
By: Lalit Mishra
Abstract Fulltext:
Lilly’s Prevail Signs Gene Editing Collaboration with Scribe Therapeutics for Neurological Diseases Published: 22 May-2023
By: Lucy Haggerty
Abstract Fulltext:
Section: Mergers & Acquisitions
Astellas Pharma to Acquire Iveric Bio for US$5.9 B Published: 10 May-2023
By: Ayush Saxena
Abstract Fulltext:
Assertio to Acquire Spectrum Pharmaceuticals for Up to US$291 M Published: 18 May-2023
By: Ashish Tripathi
Abstract Fulltext:
Ironwood to Acquire Rare Disease Specialist VectivBio for US$1 B Published: 26 May-2023
By: Lucy Haggerty
Abstract Fulltext:
Section: Research & Development
Bayer Signs US$1.7 B Deal with Bicycle Therapeutics for Cancer Radiopharmaceuticals Published: 19 May-2023
By: Amit Kaushik
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents